| human | Q5 |
| P6178 | Dimensions author ID | 01012101733.99 |
| P496 | ORCID iD | 0000-0002-6294-9380 |
| P69 | educated at | Trinity College Dublin | Q258464 |
| P108 | employer | Trinity College Dublin | Q258464 |
| P734 | family name | Doyle | Q11825166 |
| Doyle | Q11825166 | ||
| Doyle | Q11825166 | ||
| P735 | given name | ??? | Q18201513 |
| ??? | Q18201513 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q38105479 | An eye on the future of inflammasomes and drug development in AMD. |
| Q38199035 | An overview of the involvement of interleukin-18 in degenerative retinopathies. |
| Q104556088 | Attenuated CSF-1R signalling drives cerebrovascular pathology |
| Q46450466 | Author Response: The Role of IL-18 in the Treatment of AMD. |
| Q40651159 | Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. |
| Q40431320 | Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide |
| Q34965726 | Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin |
| Q39295695 | Conjugated linoleic acid suppresses IRF3 activation via modulation of CD14. |
| Q91644503 | Current perspectives on established and novel therapies for pathological neovascularization in retinal disease |
| Q90399673 | Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferons |
| Q24618242 | IL-10 inhibits miR-155 induction by toll-like receptors |
| Q35748680 | IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates |
| Q28237337 | IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration |
| Q38199024 | Inflammation in age-related macular degeneration. |
| Q86397468 | Interleukin-18 bioactivity and dose: data interpretation at a crossroads |
| Q39324207 | Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. |
| Q93133573 | Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction |
| Q40324640 | MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction |
| Q26799766 | NLRP3 Inflammasome and Pathobiology in AMD |
| Q30576000 | NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components |
| Q37132045 | Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15 |
| Q35118176 | Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor |
| Q49914681 | Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population. |
| Q86184474 | Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration |
| Q92092104 | SARM1 deficiency promotes rod and cone photoreceptor cell survival in a model of retinal degeneration |
| Q40068866 | Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase |
| Q40328896 | Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation |
| Q24321840 | TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway |
| Q34646268 | TRAM is required for TLR2 endosomal signaling to type I IFN induction |
| Q35001511 | Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives |
| Q39378070 | The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation |
| Q37497786 | Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. |
| Q88552023 | Toll-Like Receptors and Age-Related Macular Degeneration |
| Q28259757 | Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity |
| Q57793926 | Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation |
| Q38800040 | Using Confocal Microscopy to Investigate Intracellular Trafficking of Toll-Like Receptors. |
Search more.